DK3359210T3 - Periostin-fragmenter og anvendelse deraf - Google Patents

Periostin-fragmenter og anvendelse deraf Download PDF

Info

Publication number
DK3359210T3
DK3359210T3 DK16778808.2T DK16778808T DK3359210T3 DK 3359210 T3 DK3359210 T3 DK 3359210T3 DK 16778808 T DK16778808 T DK 16778808T DK 3359210 T3 DK3359210 T3 DK 3359210T3
Authority
DK
Denmark
Prior art keywords
periostin
fragments
periostin fragments
Prior art date
Application number
DK16778808.2T
Other languages
English (en)
Inventor
Serge Ferrari
Daniel S Spellman
Nicolas Bonnet
Original Assignee
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Geneve filed Critical Univ Geneve
Application granted granted Critical
Publication of DK3359210T3 publication Critical patent/DK3359210T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/108Osteoporosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
DK16778808.2T 2015-10-08 2016-10-07 Periostin-fragmenter og anvendelse deraf DK3359210T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562238901P 2015-10-08 2015-10-08
PCT/EP2016/074086 WO2017060482A1 (en) 2015-10-08 2016-10-07 Periostin fragments and use thereof

Publications (1)

Publication Number Publication Date
DK3359210T3 true DK3359210T3 (da) 2021-07-12

Family

ID=57121255

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16778808.2T DK3359210T3 (da) 2015-10-08 2016-10-07 Periostin-fragmenter og anvendelse deraf

Country Status (5)

Country Link
US (1) US11085932B2 (da)
EP (1) EP3359210B1 (da)
DK (1) DK3359210T3 (da)
ES (1) ES2885550T3 (da)
WO (1) WO2017060482A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021518387A (ja) * 2018-03-19 2021-08-02 バイオヴェンチャーズ リミテッド ライアビリティ カンパニー ペリオスチン抗体およびその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3749959B2 (ja) 1996-02-26 2006-03-01 株式会社シノテスト 磁性粒子を用いる被検物質の測定方法及び該方法に使用する測定器具
JP3762958B2 (ja) 1996-10-25 2006-04-05 株式会社シノテスト 粒子を用いる被検物質の測定方法及び該方法に使用する測定器具
SE9604378D0 (sv) 1996-11-27 1996-11-27 Tac Ab Methods and reagents for determining protein S
CA2457065A1 (en) * 2001-08-13 2003-02-27 Dana-Farber Cancer Institute, Inc. Periostin-based diagnostic assays
EP2057465A4 (en) 2006-08-09 2010-04-21 Homestead Clinical Corp SPECIFIC ORGAN PROTEINS AND METHODS OF USE
US20110033516A1 (en) 2009-08-06 2011-02-10 Medical University Of South Carolina Methods and compositions for bone healing by periostin

Also Published As

Publication number Publication date
US11085932B2 (en) 2021-08-10
EP3359210B1 (en) 2021-04-14
EP3359210A1 (en) 2018-08-15
US20180284135A1 (en) 2018-10-04
WO2017060482A1 (en) 2017-04-13
ES2885550T3 (es) 2021-12-14

Similar Documents

Publication Publication Date Title
FIC20230014I1 (fi) Foslevodopa ja foskarbidopa
DK3448386T3 (da) Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf
DK3205650T3 (da) Egfr-hæmmer og fremstilling og anvendelse deraf
DK3380101T3 (da) Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil
DK3368534T3 (da) Valbenazin-ditosylat og polymorfer deraf
DK3151985T3 (da) Bukkemaskine og tilsvarende fremgangsmåde
DK3210977T3 (da) Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3212189T3 (da) Substituerede chromaner og fremgangsmåde til anvendelse deraf
DK3354282T3 (da) Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
DK3313882T3 (da) Anti-VISTA antistoffer og fragmenter
DK2949365T3 (da) Gåtræningsapparat og gåtræningsfremgangsmåde deraf
DK3227342T3 (da) Proteinøs heterodimer og anvendelse deraf
DK3201351T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3155024T3 (da) Opholdsstrukturer og relaterede fremgangsmåder
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3319611T3 (da) Oxysteroler og fremgangsmåder til anvendelse deraf
DK3103046T3 (da) Biomarkør-signaturfremgangsmåde og apparater og kits deraf
DK3319612T3 (da) Oxysteroler og fremgansmåder til anvendelse derfor
DK3193611T3 (da) Mk2-inhibitorer og anvendelser deraf
DK3256598T3 (da) Svampestammer og anvendelsesfremgangsmåder
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3220750T3 (da) Oral rehydreringssammensætning og fremgangsmåder dertil